20190701/clinical_assertion//created/000000000000:133377:{"date_created":"2019-05-23","rcv_accession_id":"RCV000778139","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000914269.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2019-04-05","submission_id":"504895.2019-04-05","clinical_assertion_trait_set_id":"SCV000914269","interpretation_comments":["{\"text\":\"Across a selection of available literature, the ABCA4 c.6148G\u003eC (p.Val2050Leu) missense variant has been reported in at least seven individuals affected with Stargardt macular degeneration including in three in a compound heterozygous state, in one in a heterozygous state and in at least three with unknown zygosity. The variant has also been reported in two brothers affected with cone-rod dystrophy in a compound heterozygous state with a frameshift variant on the second allele, and in a heterozygous state in one individual affected with macular dystrophy (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Schulz et al. 2017; Haer-Wigman et al. 2017). The variant failed to segregate with the disorder in one family affected with autosomal recessive retinitis pigmentosa and in one with autosomal dominant macular dystrophy (Wiszniewski et al. 2005; Poloschek et al. 2010). The p.Val2050Leu variant has also been found as a complex allele in cis with either a stop-gained variant or a missense variant in individuals affected with ABCA4-related disorders (Sciezynska et al. 2016; Schulz et al. 2017). The variant was found in a heterozygous state in one of 1528 control individuals and in one unaffected parent (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Sciezynska et al. 2016). This variant is reported at a frequency of 0.028846 in Puerto Ricans from Puerto Rico from the 1000 Genomes Project and in one homozygote in the European (non-Finnish) population of the Genome Aggregation Database. Poloschek et al. (2010) showed that, upon ophthalmic examination, heterozygous carriers of the p.Val2050Leu variant display centrally reduced mfERG amplitudes and additional minor fundus abnormalities, suggesting that the p.Val2050Leu variant is capable of mildly reducing macular function in the heterozygous state without an additional pathogenic variant on the second allele. Based on the collective evidence the p.Val2050Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for ABCA4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/d4q7wshq/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26593885\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973280\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28224992\",\"@Source\":\"PubMed\"}}]}}","local_key":"909158","id":"SCV000914269","variation_archive_id":"VCV000007884","internal_id":"1789326","version":"1","date_last_updated":"2019-05-27","assertion_type":"variation to disease","trait_set_id":"33431","review_status":"criteria provided, single submitter","submission_names":["SUB5424092"]}
20190701/clinical_assertion//created/000000000000:306487:{"date_created":"2016-12-02","rcv_accession_id":"RCV000285333","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359224.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359224","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Cone-Rod Dystrophy, Recessive","id":"SCV000359224","variation_archive_id":"VCV000007884","internal_id":"672746","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33383","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
20190701/clinical_assertion//created/000000000000:316809:{"date_created":"2011-01-25","rcv_accession_id":"RCV000008335","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000028543.0"],"variation_id":"7884","interpretation_date_last_evaluated":"2016-12-29","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000028543","interpretation_comments":[],"local_key":"601691.0005_STARGARDT DISEASE 1","id":"SCV000028543","variation_archive_id":"VCV000007884","internal_id":"28543","version":"3","title":"ABCA4, VAL2050LEU_STARGARDT DISEASE 1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1448","review_status":"no assertion criteria provided","submission_names":[]}
20190701/clinical_assertion//created/000000000000:398361:{"date_created":"2014-01-16","rcv_accession_id":"RCV000259072","record_status":"current","interpretation_description":"Benign","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000110530.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-11-17","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000110530","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCA4\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?chr=1\u0026from=94467548\u0026to=94467548\"}}]}}","local_key":"11450_000000","id":"SCV000110530","variation_archive_id":"VCV000007884","internal_id":"192622","version":"8","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
20190701/clinical_assertion//created/000000000001:126050:{"date_created":"2014-02-18","rcv_accession_id":"RCV000078671","record_status":"current","interpretation_description":"not provided","submitter_id":"500304","clinical_assertion_observation_ids":["SCV000117933.0"],"variation_id":"7884","submission_id":"500304.2012-12-20","clinical_assertion_trait_set_id":"SCV000117933","interpretation_comments":[],"content":"{\"Comment\":{\"$\":\"http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19\u0026id=RISN_ABCR:c.6148G\u003eC\",\"@Type\":\"public\"}}","local_key":"RISN-ABCR:c.6148G\u003eC","id":"SCV000117933","variation_archive_id":"VCV000007884","internal_id":"205773","version":"1","date_last_updated":"2019-04-19","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"no assertion provided","submission_names":["RISN_LSDB_112012"]}
20190701/clinical_assertion//created/000000000001:165518:{"date_created":"2017-09-07","rcv_accession_id":"RCV000504806","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505998","clinical_assertion_observation_ids":["SCV000599010.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-01-01","submission_id":"505998.2017-08-18","clinical_assertion_trait_set_id":"SCV000599010","interpretation_comments":[],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","local_key":"c.6148G\u003eC_HP:0000548","id":"SCV000599010","variation_archive_id":"VCV000007884","internal_id":"1160860","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33742","review_status":"no assertion criteria provided","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"]}
20190701/clinical_assertion//created/000000000001:246774:{"date_created":"2016-12-02","rcv_accession_id":"RCV000340261","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359225.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359225","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Stargardt Disease, Recessive","id":"SCV000359225","variation_archive_id":"VCV000007884","internal_id":"672747","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33430","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
20190701/clinical_assertion//created/000000000001:267403:{"date_created":"2016-12-02","rcv_accession_id":"RCV000393715","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359223.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359223","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Retinitis Pigmentosa, Recessive","id":"SCV000359223","variation_archive_id":"VCV000007884","internal_id":"672745","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33382","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
20190701/clinical_assertion//created/000000000001:285022:{"date_created":"2016-12-02","rcv_accession_id":"RCV000393726","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359226.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359226","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Macular Degeneration","id":"SCV000359226","variation_archive_id":"VCV000007884","internal_id":"672748","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33398","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
20190701/clinical_assertion//created/000000000001:313267:{"date_created":"2016-06-16","rcv_accession_id":"RCV000008335","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505832","clinical_assertion_observation_ids":["SCV000281950.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-01-01","submission_id":"505832.2016-05-25","clinical_assertion_trait_set_id":"SCV000281950","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Schulz et al. (Invest Ophthalmol Vis Sci. 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}]}}","local_key":"162","id":"SCV000281950","variation_archive_id":"VCV000007884","internal_id":"533093","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1448","review_status":"criteria provided, single submitter","submission_names":["STGD2016"]}
20190701/clinical_assertion//created/000000000001:322078:{"date_created":"2017-03-03","rcv_accession_id":"RCV000078671","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000511911.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-11-07","submission_id":"26957.2019-01-29","clinical_assertion_trait_set_id":"SCV000511911","interpretation_comments":["{\"text\":\"The V2050L variant in the ABCA4 gene has been reported previously in association with Stargardt disease, macular dystrophy, cone-rod dystrophy, and age-related macular degeneration (Lewis et al., 1999; Wiszniewski et al., 2005; Poloschek et al., 2010; Fritsche et al., 2012; Corton et al., 2013). Poloschek et al. (2010) reported that V2050L heterozygous carriers show centrally reduced mfERG amplitudes and additional minor fundus abnormalities, which suggested that the V2050L variant in the heterozygous state is capable of mildly reducing macular function without an additional pathogenic variant on the second allele. However, the V2050L variant is observed in 202/34420 (0.5869%) alleles from individuals of Latino background and 787/277174 (0.2839%) global alleles, with one homozygote reported (Lek et al., 2016). The V2050L variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret V2050L as a variant of uncertain significance.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:874|Not Provided","id":"SCV000511911","variation_archive_id":"VCV000007884","internal_id":"977225","version":"3","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB5098196"]}
20190731/clinical_assertion//created/000000000000:453:{"local_key":"NM_000350.2:c.6148G\u003eC|MedGen:C0035334","interpretation_date_last_evaluated":"2018-04-01","id":"SCV000926774","submission_id":"1147.2018-12-05","record_status":"current","rcv_accession_id":"RCV000787769","version":"1","submitted_assembly":"GRCh37","clinical_assertion_trait_set_id":"SCV000926774","interpretation_comments":[],"interpretation_description":"Pathogenic","clinical_assertion_observation_ids":["SCV000926774.0"],"internal_id":"1812551","variation_archive_id":"VCV000007884","variation_id":"7884","assertion_type":"variation to disease","submitter_id":"1147","date_created":"2019-07-19","review_status":"no assertion criteria provided","date_last_updated":"2019-07-22","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"Investigation of 124 genes associated with retinal dystrophies\"},\"StudyName\":{\"$\":\"VeluxRD\"}}","trait_set_id":"6496","submission_names":["SUB4878664"]}
20190902/clinical_assertion//updated/000000000000:1444:{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"Investigation of 124 genes associated with retinal dystrophies\"},\"StudyName\":{\"$\":\"VeluxRD\"}}","date_created":"2019-07-19","clinical_assertion_observation_ids":["SCV000926774.0"],"submitter_id":"1147","date_last_updated":"2019-08-03","trait_set_id":"6496","review_status":"no assertion criteria provided","variation_archive_id":"VCV000007884","interpretation_description":"Pathogenic","submission_id":"1147.2018-12-05","submission_names":["SUB4878664"],"rcv_accession_id":"RCV000787769","internal_id":"1812551","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000926774","local_key":"NM_000350.2:c.6148G\u003eC|MedGen:C0035334","record_status":"current","interpretation_date_last_evaluated":"2018-04-01","id":"SCV000926774","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:35629:{"assertion_type":"variation to disease","version":"1","content":"{\"Comment\":{\"$\":\"http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19\u0026id=RISN_ABCR:c.6148G\u003eC\"}}","date_created":"2014-02-18","clinical_assertion_observation_ids":["SCV000117933.0"],"submitter_id":"500304","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"no assertion provided","variation_archive_id":"VCV000007884","interpretation_description":"not provided","submission_id":"500304.2012-12-20","submission_names":["RISN_LSDB_112012"],"rcv_accession_id":"RCV000078671","internal_id":"205773","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000117933","local_key":"RISN-ABCR:c.6148G\u003eC","record_status":"current","id":"SCV000117933","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:43726:{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/d4q7wshq/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26593885\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973280\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28224992\",\"@Source\":\"PubMed\"}}]}}","date_created":"2019-05-23","clinical_assertion_observation_ids":["SCV000914269.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33431","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","submission_id":"504895.2019-04-05","submission_names":["SUB5424092"],"rcv_accession_id":"RCV000778139","internal_id":"1789326","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000914269","local_key":"909158","record_status":"current","interpretation_date_last_evaluated":"2019-04-05","id":"SCV000914269","interpretation_comments":["{\"text\":\"Across a selection of available literature, the ABCA4 c.6148G\u003eC (p.Val2050Leu) missense variant has been reported in at least seven individuals affected with Stargardt macular degeneration including in three in a compound heterozygous state, in one in a heterozygous state and in at least three with unknown zygosity. The variant has also been reported in two brothers affected with cone-rod dystrophy in a compound heterozygous state with a frameshift variant on the second allele, and in a heterozygous state in one individual affected with macular dystrophy (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Schulz et al. 2017; Haer-Wigman et al. 2017). The variant failed to segregate with the disorder in one family affected with autosomal recessive retinitis pigmentosa and in one with autosomal dominant macular dystrophy (Wiszniewski et al. 2005; Poloschek et al. 2010). The p.Val2050Leu variant has also been found as a complex allele in cis with either a stop-gained variant or a missense variant in individuals affected with ABCA4-related disorders (Sciezynska et al. 2016; Schulz et al. 2017). The variant was found in a heterozygous state in one of 1528 control individuals and in one unaffected parent (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Sciezynska et al. 2016). This variant is reported at a frequency of 0.028846 in Puerto Ricans from Puerto Rico from the 1000 Genomes Project and in one homozygote in the European (non-Finnish) population of the Genome Aggregation Database. Poloschek et al. (2010) showed that, upon ophthalmic examination, heterozygous carriers of the p.Val2050Leu variant display centrally reduced mfERG amplitudes and additional minor fundus abnormalities, suggesting that the p.Val2050Leu variant is capable of mildly reducing macular function in the heterozygous state without an additional pathogenic variant on the second allele. Based on the collective evidence the p.Val2050Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for ABCA4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\"}"]}
20190902/clinical_assertion//updated/000000000000:58858:{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-09-07","clinical_assertion_observation_ids":["SCV000599010.0"],"submitter_id":"505998","date_last_updated":"2019-08-03","trait_set_id":"33742","review_status":"no assertion criteria provided","variation_archive_id":"VCV000007884","interpretation_description":"Likely pathogenic","submission_id":"505998.2017-08-18","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"],"rcv_accession_id":"RCV000504806","internal_id":"1160860","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000599010","local_key":"c.6148G\u003eC_HP:0000548","record_status":"current","interpretation_date_last_evaluated":"2015-01-01","id":"SCV000599010","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:96773:{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359223.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33382","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000393715","internal_id":"672745","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359223","local_key":"293398|Retinitis Pigmentosa, Recessive","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359223","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:97077:{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359224.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33383","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000285333","internal_id":"672746","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359224","local_key":"293398|Cone-Rod Dystrophy, Recessive","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359224","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:97440:{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359225.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33430","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000340261","internal_id":"672747","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359225","local_key":"293398|Stargardt Disease, Recessive","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359225","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:97544:{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359226.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33398","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000393726","internal_id":"672748","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359226","local_key":"293398|Macular Degeneration","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359226","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:98352:{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Schulz et al. (Invest Ophthalmol Vis Sci. 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-06-16","clinical_assertion_observation_ids":["SCV000281950.0"],"submitter_id":"505832","date_last_updated":"2019-08-03","trait_set_id":"1448","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely pathogenic","submission_id":"505832.2016-05-25","submission_names":["STGD2016"],"rcv_accession_id":"RCV000008335","internal_id":"533093","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000281950","local_key":"162","record_status":"current","interpretation_date_last_evaluated":"2016-01-01","id":"SCV000281950","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:102755:{"assertion_type":"variation to disease","version":"3","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000028543.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"1448","review_status":"no assertion criteria provided","variation_archive_id":"VCV000007884","interpretation_description":"Pathogenic","submission_id":"3.2010-12-30","submission_names":[],"title":"ABCA4, VAL2050LEU_STARGARDT DISEASE 1","rcv_accession_id":"RCV000008335","internal_id":"28543","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000028543","local_key":"601691.0005_STARGARDT DISEASE 1","record_status":"current","interpretation_date_last_evaluated":"2016-12-29","id":"SCV000028543","interpretation_comments":[]}
20190902/clinical_assertion//updated/000000000000:105753:{"assertion_type":"variation to disease","version":"3","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2017-03-03","clinical_assertion_observation_ids":["SCV000511911.0"],"submitter_id":"26957","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","submission_id":"26957.2019-01-29","submission_names":["SUB5098196"],"rcv_accession_id":"RCV000078671","internal_id":"977225","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000511911","local_key":"GDX:874|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2018-11-07","id":"SCV000511911","interpretation_comments":["{\"text\":\"The V2050L variant in the ABCA4 gene has been reported previously in association with Stargardt disease, macular dystrophy, cone-rod dystrophy, and age-related macular degeneration (Lewis et al., 1999; Wiszniewski et al., 2005; Poloschek et al., 2010; Fritsche et al., 2012; Corton et al., 2013). Poloschek et al. (2010) reported that V2050L heterozygous carriers show centrally reduced mfERG amplitudes and additional minor fundus abnormalities, which suggested that the V2050L variant in the heterozygous state is capable of mildly reducing macular function without an additional pathogenic variant on the second allele. However, the V2050L variant is observed in 202/34420 (0.5869%) alleles from individuals of Latino background and 787/277174 (0.2839%) global alleles, with one homozygote reported (Lek et al., 2016). The V2050L variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret V2050L as a variant of uncertain significance.\"}"]}
20190902/clinical_assertion//updated/000000000000:150551:{"assertion_type":"variation to disease","version":"8","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCA4\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?chr=1\u0026from=94467548\u0026to=94467548\"}}]}}","date_created":"2014-01-16","clinical_assertion_observation_ids":["SCV000110530.0"],"submitter_id":"500060","date_last_updated":"2019-08-03","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Benign","submission_id":"500060.2018-09-19","submission_names":["SUB4534263"],"rcv_accession_id":"RCV000259072","internal_id":"192622","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000110530","local_key":"11450_000000","record_status":"current","interpretation_date_last_evaluated":"2016-11-17","id":"SCV000110530","interpretation_comments":[]}
20191001/clinical_assertion//updated/000000000000:11498:{"submitted_assembly":"GRCh37","version":"1","date_last_updated":"2019-09-04","submission_id":"505998.2017-08-18","interpretation_description":"Likely pathogenic","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":[],"submitter_id":"505998","clinical_assertion_trait_set_id":"SCV000599010","review_status":"no assertion criteria provided","trait_set_id":"33742","interpretation_date_last_evaluated":"2015-01-01","id":"SCV000599010","assertion_type":"variation to disease","record_status":"current","local_key":"c.6148G\u003eC_HP:0000548","internal_id":"1160860","date_created":"2017-09-07","variation_id":"7884","variation_archive_id":"VCV000007884","clinical_assertion_observation_ids":["SCV000599010.0"],"rcv_accession_id":"RCV000504806"}
20191231/clinical_assertion//created/000000000000:19274:{"interpretation_date_last_evaluated":"2019-02-26","id":"SCV001037250","trait_set_id":"9460","submission_names":["SUB5321749"],"submission_id":"500031.2019-03-14","interpretation_description":"Benign","version":"1","local_key":"2281434|MedGen:CN517202","variation_id":"7884","interpretation_comments":[],"clinical_assertion_observation_ids":["SCV001037250.0"],"rcv_accession_id":"RCV000078671","variation_archive_id":"VCV000007884","assertion_type":"variation to disease","record_status":"current","date_created":"2019-12-11","submitted_assembly":"GRCh37","review_status":"criteria provided, single submitter","date_last_updated":"2019-12-19","internal_id":"2005121","clinical_assertion_trait_set_id":"SCV001037250","submitter_id":"500031","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Nykamp K et al. (Genet Med 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}"}
20191231/clinical_assertion//updated/000000000000:23753:{"submission_id":"500304.2012-12-20","record_status":"current","rcv_accession_id":"RCV000078671","version":"1","date_created":"2014-02-18","interpretation_comments":[],"variation_id":"7884","id":"SCV000117933","clinical_assertion_trait_set_id":"SCV000117933","submission_names":["RISN_LSDB_112012"],"variation_archive_id":"VCV000007884","content":"{\"Comment\":{\"$\":\"http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19\u0026id=RISN_ABCR:c.6148G\u003eC\"}}","clinical_assertion_observation_ids":["SCV000117933.0"],"local_key":"RISN-ABCR:c.6148G\u003eC","assertion_type":"variation to disease","submitter_id":"500304","interpretation_description":"not provided","review_status":"no assertion provided","internal_id":"205773","trait_set_id":"9460","date_last_updated":"2019-12-17"}
20191231/clinical_assertion//updated/000000000000:63052:{"submission_id":"26957.2019-01-29","record_status":"current","rcv_accession_id":"RCV000078671","version":"3","date_created":"2017-03-03","interpretation_comments":["{\"text\":\"The V2050L variant in the ABCA4 gene has been reported previously in association with Stargardt disease, macular dystrophy, cone-rod dystrophy, and age-related macular degeneration (Lewis et al., 1999; Wiszniewski et al., 2005; Poloschek et al., 2010; Fritsche et al., 2012; Corton et al., 2013). Poloschek et al. (2010) reported that V2050L heterozygous carriers show centrally reduced mfERG amplitudes and additional minor fundus abnormalities, which suggested that the V2050L variant in the heterozygous state is capable of mildly reducing macular function without an additional pathogenic variant on the second allele. However, the V2050L variant is observed in 202/34420 (0.5869%) alleles from individuals of Latino background and 787/277174 (0.2839%) global alleles, with one homozygote reported (Lek et al., 2016). The V2050L variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret V2050L as a variant of uncertain significance.\"}"],"interpretation_date_last_evaluated":"2018-11-07","variation_id":"7884","id":"SCV000511911","clinical_assertion_trait_set_id":"SCV000511911","submission_names":["SUB5098196"],"variation_archive_id":"VCV000007884","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","clinical_assertion_observation_ids":["SCV000511911.0"],"local_key":"GDX:874|Not Provided","assertion_type":"variation to disease","submitter_id":"26957","interpretation_description":"Uncertain significance","review_status":"criteria provided, single submitter","internal_id":"977225","trait_set_id":"9460","date_last_updated":"2019-12-17","submitted_assembly":"GRCh37"}
20200203/clinical_assertion//created/000000000000:7329:{"id":"SCV001135324","submission_names":["MENDELICS_CLINVAR_020"],"submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2019-05-28","variation_archive_id":"VCV000007884","rcv_accession_id":"RCV000008335","date_last_updated":"2020-01-13","clinical_assertion_observation_ids":["SCV001135324.0"],"review_status":"criteria provided, single submitter","assertion_type":"variation to disease","interpretation_description":"Uncertain significance","date_created":"2020-01-07","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV001135324","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","trait_set_id":"1448","submitter_id":"500035","version":"1","local_key":"NC_000001.10:g.94467548C\u003eG|OMIM:248200","internal_id":"2241123","variation_id":"7884","submission_id":"500035.2019-10-22"}
20200203/clinical_assertion//created/000000000000:19412:{"id":"SCV001147323","submission_names":["2019-07"],"submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-10-01","variation_archive_id":"VCV000007884","rcv_accession_id":"RCV000078671","date_last_updated":"2020-02-03","clinical_assertion_observation_ids":["SCV001147323.0"],"review_status":"criteria provided, single submitter","assertion_type":"variation to disease","interpretation_description":"Uncertain significance","date_created":"2020-01-30","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV001147323","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","trait_set_id":"9460","submitter_id":"505870","version":"1","local_key":":Chr.1_94467548_94467548_C_G|MedGen:CN517202","internal_id":"2265511","variation_id":"7884","submission_id":"505870.2019-07-12"}
20200302/clinical_assertion//created/000000000000:7097:{"clinical_assertion_trait_set_id":"SCV001159506","variation_archive_id":"VCV000007884","trait_set_id":"9590","local_key":"349329|MedGen:CN169374","date_created":"2020-02-07","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2019-04-09","internal_id":"2284080","interpretation_comments":["{\"text\":\"The ABCA4 c.6148G\u003eC; p.Val2050Leu variant (rs41292677) is reported in the literature in multiple individuals affected with Stargardt disease, retinitis pigmentosa, or a related retinal disorder (Allikmets 1997, Corton 2013, Haer-Wigman 2017, Sciezynska 2016, Wiszniewski 2005). This variant has been observed in trans to a pathogenic variant in affected individuals (Corton 2013); however, it has also been observed in cis to a nonsense variant in at least one study (Sciezynska 2016). The p.Val2050Leu variant is found in the Latino population with an overall allele frequency of 0.60% (211/35438 alleles) in the Genome Aggregation Database and is reported with conflicting classifications in ClinVar (Variation ID: 7884). The leucine at codon 2050 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: damaging) predict conflicting effects of this variant on protein structure/function. Due to conflicting information, the clinical significance of the p.Val2050Leu variant is uncertain at this time. References: Allikmets R et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997 Mar;15(3):236-46. Corton M et al. Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. PLoS One. 2013 Jun 14;8(6):e65574. Haer-Wigman L et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment. Eur J Hum Genet. 2017 May;25(5):591-599. Sciezynska A et al. Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe. Exp Eye Res. 2016 Apr;145:93-99. Wiszniewski W et al. ABCA4 mutations causing mislocalization are found frequently in patients with severe retinal dystrophies. Hum Mol Genet. 2005 Oct 1;14(19):2769-78.\"}"],"assertion_type":"variation to disease","submitted_assembly":"not applicable","submitter_id":"25969","review_status":"criteria provided, single submitter","version":"1","record_status":"current","variation_id":"7884","clinical_assertion_observation_ids":["SCV001159506.0"],"interpretation_description":"Uncertain significance","date_last_updated":"2020-02-10","submission_names":["Aug 2019 ARUP"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","id":"SCV001159506","rcv_accession_id":"RCV000259072"}
20200506/clinical_assertion//created/000000000000:4884:{"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Blueprint Genetics Variant Classification Scheme\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/8okxtmpf/blueprint_genetics_variant_classification_scheme.pdf\"}}},\"Comment\":{\"$\":\"My Retina Tracker patient\"}}","submitter_id":"500188","clinical_assertion_trait_set_id":"SCV001241289","clinical_assertion_observation_ids":["SCV001241289.0"],"local_key":"NM_000350.2:c.6148G\u003eC|Retinal dystrophy","review_status":"criteria provided, single submitter","submitted_assembly":"GRCh37","id":"SCV001241289","submission_id":"500188.2019-10-15","assertion_type":"variation to disease","trait_set_id":"12366","version":"1","interpretation_date_last_evaluated":"2019-03-07","internal_id":"2444608","record_status":"current","interpretation_description":"Uncertain significance","interpretation_comments":[],"date_last_updated":"2020-04-19","date_created":"2020-04-16","submission_names":["SUB6252865"],"variation_id":"7884","variation_archive_id":"VCV000007884","rcv_accession_id":"RCV001075661"}
20200506/clinical_assertion//updated/000000000000:56074:{"id":"SCV001037250","clinical_assertion_trait_set_id":"SCV001037250","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2005121","clinical_assertion_observation_ids":["SCV001037250.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000007884","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-11","submitter_id":"500031","rcv_accession_id":"RCV000078671","submission_names":["SUB6897608"],"local_key":"2281434|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"7884"}
20200602/clinical_assertion//updated/000000000000:4678:{"date_created":"2019-12-11","interpretation_comments":[],"submission_id":"500031.2020-01-29","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2019-12-31","interpretation_description":"Benign","version":"2","date_last_updated":"2020-05-05","assertion_type":"variation to disease","record_status":"current","trait_set_id":"9460","variation_archive_id":"VCV000007884","internal_id":"2005121","variation_id":"7884","review_status":"criteria provided, single submitter","rcv_accession_id":"RCV000078671","submission_names":["SUB6897608"],"local_key":"2281434|MedGen:CN517202","id":"SCV001037250","clinical_assertion_observation_ids":["SCV001037250.0"],"clinical_assertion_trait_set_id":"SCV001037250","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submitter_id":"500031"}
20200602/clinical_assertion//updated/000000000000:98680:{"date_created":"2020-01-30","interpretation_comments":[],"submission_id":"505870.2020-02-27","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2019-11-01","interpretation_description":"Uncertain significance","version":"2","date_last_updated":"2020-05-12","assertion_type":"variation to disease","record_status":"current","trait_set_id":"9460","variation_archive_id":"VCV000007884","internal_id":"2265511","variation_id":"7884","review_status":"criteria provided, single submitter","rcv_accession_id":"RCV000078671","submission_names":["2020-02-corrected"],"local_key":":Chr.1_94467548_94467548_C_G|MedGen:CN517202","id":"SCV001147323","clinical_assertion_observation_ids":["SCV001147323.0"],"clinical_assertion_trait_set_id":"SCV001147323","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","submitter_id":"505870"}
20200609/clinical_assertion//updated/000000000000:1182:{"date_last_updated":"2020-06-07","submitted_assembly":"GRCh37","variation_archive_id":"VCV000007884","variation_id":"7884","assertion_type":"variation to disease","submission_names":["2020-04"],"record_status":"current","clinical_assertion_observation_ids":["SCV001147323.0"],"clinical_assertion_trait_set_id":"SCV001147323","interpretation_comments":[],"trait_set_id":"9460","review_status":"criteria provided, single submitter","version":"3","id":"SCV001147323","rcv_accession_id":"RCV000078671","interpretation_description":"Uncertain significance","submission_id":"505870.2020-05-18","internal_id":"2265511","date_created":"2020-01-30","submitter_id":"505870","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","interpretation_date_last_evaluated":"2019-11-01","local_key":"1866|MedGen:CN517202"}
20200615/clinical_assertion//updated/000000000000:2229:{"trait_set_id":"9460","assertion_type":"variation to disease","interpretation_description":"Uncertain significance","submission_id":"505870.2020-05-18","date_last_updated":"2020-06-08","version":"3","submission_names":["2020-04"],"clinical_assertion_trait_set_id":"SCV001147323","internal_id":"2265511","submitter_id":"505870","review_status":"criteria provided, single submitter","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","interpretation_comments":[],"date_created":"2020-01-30","variation_id":"7884","interpretation_date_last_evaluated":"2019-11-01","id":"SCV001147323","variation_archive_id":"VCV000007884","record_status":"current","submitted_assembly":"GRCh37","local_key":"1866|MedGen:CN517202","clinical_assertion_observation_ids":["SCV001147323.0"],"rcv_accession_id":"RCV000078671"}
20200717/clinical_assertion//updated/000000000000:5528:{"clinical_assertion_trait_set_id":"SCV001147323","interpretation_description":"Uncertain significance","local_key":"1866|MedGen:CN517202","submitted_assembly":"GRCh37","submission_id":"505870.2020-07-06","variation_archive_id":"VCV000007884","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","interpretation_comments":[],"interpretation_date_last_evaluated":"2019-11-01","id":"SCV001147323","date_created":"2020-01-30","assertion_type":"variation to disease","submitter_id":"505870","trait_set_id":"9460","internal_id":"2265511","review_status":"criteria provided, single submitter","date_last_updated":"2020-07-11","clinical_assertion_observation_ids":["SCV001147323.0"],"rcv_accession_id":"RCV000078671","variation_id":"7884","submission_names":["2020-07"],"version":"4"}
20200720/clinical_assertion//updated/000000000000:1562:{"interpretation_date_last_evaluated":"2019-11-01","clinical_assertion_trait_set_id":"SCV001147323","local_key":"1866|MedGen:CN517202","internal_id":"2265511","submitter_id":"505870","id":"SCV001147323","record_status":"current","trait_set_id":"9460","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","date_last_updated":"2020-07-16","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","rcv_accession_id":"RCV000078671","clinical_assertion_observation_ids":["SCV001147323.0"],"assertion_type":"variation to disease","variation_id":"7884","version":"4","review_status":"criteria provided, single submitter","submission_names":["2020-07"],"submitted_assembly":"GRCh37","submission_id":"505870.2020-07-06","date_created":"2020-01-30"}
20200817/clinical_assertion//updated/000000000000:30784:{"date_created":"2020-02-07","interpretation_date_last_evaluated":"2019-04-09","submission_names":["Aug 2019 ARUP"],"submitter_id":"25969","interpretation_comments":["{\"text\":\"The ABCA4 c.6148G\u003eC; p.Val2050Leu variant (rs41292677) is reported in the literature in multiple individuals affected with Stargardt disease, retinitis pigmentosa, or a related retinal disorder (Allikmets 1997, Corton 2013, Haer-Wigman 2017, Sciezynska 2016, Wiszniewski 2005). This variant has been observed in trans to a pathogenic variant in affected individuals (Corton 2013); however, it has also been observed in cis to a nonsense variant in at least one study (Sciezynska 2016). The p.Val2050Leu variant is found in the Latino population with an overall allele frequency of 0.60% (211/35438 alleles) in the Genome Aggregation Database and is reported with conflicting classifications in ClinVar (Variation ID: 7884). The leucine at codon 2050 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: damaging) predict conflicting effects of this variant on protein structure/function. Due to conflicting information, the clinical significance of the p.Val2050Leu variant is uncertain at this time. References: Allikmets R et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997 Mar;15(3):236-46. Corton M et al. Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. PLoS One. 2013 Jun 14;8(6):e65574. Haer-Wigman L et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment. Eur J Hum Genet. 2017 May;25(5):591-599. Sciezynska A et al. Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe. Exp Eye Res. 2016 Apr;145:93-99. Wiszniewski W et al. ABCA4 mutations causing mislocalization are found frequently in patients with severe retinal dystrophies. Hum Mol Genet. 2005 Oct 1;14(19):2769-78.\"}"],"record_status":"current","variation_id":"7884","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","submitted_assembly":"not applicable","clinical_assertion_observation_ids":["SCV001159506.0"],"version":"1","trait_set_id":"9590","rcv_accession_id":"RCV000259072","internal_id":"2284080","submission_id":"25969.2019-08-05","interpretation_description":"Uncertain significance","assertion_type":"variation to disease","clinical_assertion_trait_set_id":"SCV001159506","local_key":"349329|MedGen:CN169374","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","date_last_updated":"2020-08-12","id":"SCV001159506"}
20201010/clinical_assertion//updated/000000000000:96092:{"id":"SCV001159506","record_status":"current","date_created":"2020-02-07","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","variation_id":"7884","rcv_accession_id":"RCV000259072","internal_id":"2284080","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"The ABCA4 c.6148G\u003eC; p.Val2050Leu variant (rs41292677) is reported in the literature in multiple individuals affected with Stargardt disease, retinitis pigmentosa, or a related retinal disorder (Allikmets 1997, Corton 2013, Haer-Wigman 2017, Sciezynska 2016, Wiszniewski 2005). This variant has been observed in trans to a pathogenic variant in affected individuals (Corton 2013); however, it has also been observed in cis to a nonsense variant in at least one study (Sciezynska 2016). The p.Val2050Leu variant is found in the Latino population with an overall allele frequency of 0.60% (211/35438 alleles) in the Genome Aggregation Database and is reported with conflicting classifications in ClinVar (Variation ID: 7884). The leucine at codon 2050 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: damaging) predict conflicting effects of this variant on protein structure/function. Due to conflicting information, the clinical significance of the p.Val2050Leu variant is uncertain at this time. References: Allikmets R et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997 Mar;15(3):236-46. Corton M et al. Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. PLoS One. 2013 Jun 14;8(6):e65574. Haer-Wigman L et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment. Eur J Hum Genet. 2017 May;25(5):591-599. Sciezynska A et al. Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe. Exp Eye Res. 2016 Apr;145:93-99. Wiszniewski W et al. ABCA4 mutations causing mislocalization are found frequently in patients with severe retinal dystrophies. Hum Mol Genet. 2005 Oct 1;14(19):2769-78.\"}"],"local_key":"349329|MedGen:CN169374","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2019-08-05","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV001159506","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2019-04-09","clinical_assertion_observation_ids":["SCV001159506.0"],"date_last_updated":"2020-10-06","version":"1","submission_names":["Aug 2019 ARUP"],"submitter_id":"25969","submitted_assembly":"not applicable"}
